Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter D. Caravan, Ph.D.

Co-Author

Back to Details
This page shows the publications co-authored by Peter Caravan and Raymond Chung.
Peter Caravan
Connection Strength
0.451
Raymond Chung
  1. Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis. Hepatol Commun. 2018 May; 2(5):529-545.
    View in: PubMed
    Score: 0.188
  2. T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg. 2016 Apr; 6(2):103-14.
    View in: PubMed
    Score: 0.164
  3. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver. Cell Mol Gastroenterol Hepatol. 2022 Jan 28.
    View in: PubMed
    Score: 0.061
  4. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep. 2014 Dec 01; 2(4):245-256.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.